Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.15 and traded as low as $0.13. Elite Pharmaceuticals shares last traded at $0.13, with a volume of 438,341 shares traded.
Elite Pharmaceuticals Trading Down 4.4 %
The company has a fifty day moving average of $0.14 and a two-hundred day moving average of $0.15. The company has a current ratio of 1.94, a quick ratio of 1.19 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $134.87 million, a price-to-earnings ratio of 12.63 and a beta of -0.08.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- Why is the Ex-Dividend Date Significant to Investors?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is the FTSE 100 index?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is the Dow Jones Industrial Average (DJIA)?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
